BEAM
Price
$21.60
Change
-$1.14 (-5.01%)
Updated
Apr 25, 6:59 PM EST
11 days until earnings call
EDIT
Price
$5.22
Change
-$0.13 (-2.43%)
Updated
Apr 25, 6:59 PM EST
6 days until earnings call
Ad is loading...

Compare trend and price BEAM vs EDIT

Header iconBEAM vs EDIT Comparison
Open Charts BEAM vs EDITBanner chart's image
Beam Therapeutics
Price$21.60
Change-$1.14 (-5.01%)
Volume$885.28K
CapitalizationN/A
Editas Medicine
Price$5.22
Change-$0.13 (-2.43%)
Volume$927.69K
CapitalizationN/A
View a ticker or compare two or three
BEAM vs EDIT Comparison Chart

Loading...

BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
EDITDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BEAM vs. EDIT commentary
Apr 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and EDIT is a Hold.

COMPARISON
Comparison
Apr 26, 2024
Stock price -- (BEAM: $22.74 vs. EDIT: $5.35)
Brand notoriety: BEAM and EDIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 72% vs. EDIT: 95%
Market capitalization -- BEAM: $1.78B vs. EDIT: $439.96M
BEAM [@Biotechnology] is valued at $1.78B. EDIT’s [@Biotechnology] market capitalization is $439.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $562.44B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileEDIT’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • EDIT’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than EDIT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 2 TA indicator(s) are bullish while EDIT’s TA Score has 2 bullish TA indicator(s).

  • BEAM’s TA Score: 2 bullish, 4 bearish.
  • EDIT’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, EDIT is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -6.46% price change this week, while EDIT (@Biotechnology) price change was -4.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.02%. For the same industry, the average monthly price growth was -8.35%, and the average quarterly price growth was +1260.86%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 06, 2024.

EDIT is expected to report earnings on Jul 31, 2024.

Industries' Descriptions

@Biotechnology (-1.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
A.I.dvisor published
a Summary for EDIT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BEAM($1.78B) has a higher market cap than EDIT($440M). BEAM YTD gains are higher at: -16.458 vs. EDIT (-47.187).
BEAMEDITBEAM / EDIT
Capitalization1.78B440M404%
EBITDAN/AN/A-
Gain YTD-16.458-47.18735%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMEDIT
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
EDITDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRKAX13.040.12
+0.93%
MFS Blended Research Em Mkts Eq A
SMUYX9.570.01
+0.10%
SEI Multi-Strategy Alternative Y (SIMT)
TWDAX16.390.01
+0.06%
Templeton World Adv
AIEAX18.40-0.02
-0.11%
American Beacon International Eq A
HCAIX96.08-0.40
-0.41%
Harbor Capital Appreciation Inv

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been closely correlated with NTLA. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if EDIT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
-2.01%
NTLA - EDIT
68%
Closely correlated
-1.67%
BEAM - EDIT
63%
Loosely correlated
-3.11%
AXON - EDIT
52%
Loosely correlated
+0.28%
VCYT - EDIT
49%
Loosely correlated
+0.35%
ALLO - EDIT
48%
Loosely correlated
-9.79%
More